US30050B1017
US30050B1017
Evolent Health, Inc
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.876.229.000 | 2.554.741.000 | 26.6% |
| Cost of Revenue | 1.476.346.000 | 2.187.388.000 | 32.5% |
| Gross Profit | 399.883.000 | 367.353.000 | 8.9% |
| 419.717.000 | 381.420.000 | 10.0% | |
| Operating Income | -19.834.000 | -14.067.000 | 41.0% |
| Pretax Income | -534.636.000 | -63.036.000 | 748.1% |
| Net Income Common Stockholders | -579.401.000 | -93.454.000 | 520.0% |
| -- | -- | -- | |
| -- | -- | -- |